Clinical features and outcomes of 210 patients with idiopathic pulmonary fibrosis

被引:0
|
作者
Cai Miaotian [1 ,2 ,3 ]
Zhu Min [1 ,2 ]
Ban Chengjun [1 ,2 ]
Su Jin [1 ,2 ]
Ye Qiao [1 ,2 ]
Liu Yan [1 ,2 ]
Zhao Wen [1 ,2 ]
Wang Chen [2 ,4 ]
Dai Huaping [1 ,2 ]
机构
[1] Department of Respiratory and Critical Care Medicine,Beijing Chao-Yang Hospital,Capital Medical University
[2] Beijing Key Laboratory of Respiratory and Pulmonary Circulation,Beijing Institute of Respiratory Medicine
[3] Beijing Youan Hospital,Capital Medical University
[4] Beijing Hospital,National Clinical Research Center for Respiratory Medicine
基金
国科技部“十一五”科技计划项目;
关键词
D O I
暂无
中图分类号
R563 [肺疾病];
学科分类号
1002 ; 100201 ;
摘要
Background Idiopathic pulmonary fibrosis(IPF) is a lethal chronic interstitial lung disease(ILD) of unknown cause and having a variable and unpredictable course. This study aimed to summarize the clinical features and follow-up outcomes and to identify potential factors useful for the assessment of prognosis in IPF.Methods Two hundred and ten patients hospitalized and diagnosed as IPF in our unit from January 1999 to June 2007 were enrolled into this study. The baseline demographic, clinical, radiologic and physiologic characteristics were summarized. Clinical follow-up data until February 2010 were collected, and the median survival time and 1-, 2-, and 5-year survival rates, as well as the influences of the summarized baseline variables on the prognosis were analyzed.Results The age at diagnosis as IPF was(64±10) years, the duration before diagnosis of 106 patients(50%) was shorter than 2 years, and 73% were males. One hundred and forty-five patients(69%) had a history of smoking with a median pack-year of 18. Eighty-nine patients(42%) had emphysema and 62 patients(29%) pulmonary arterial hypertension(PAH). One hundred and twenty-four patients were followed up, of which 99 patients died from various causes including respiratory failure related to IPF(93%). The follow-up period was(21±23) months. The median survival time was 38 months. The 1-, 2-, and 5-year survival rates were 61%, 52%, and 39%, respectively. Multivariate analysis showed clubbing, PAH, duration from initial onset to diagnosis, and forced expiratory volume in 1 second(FEV1)/forced vital capacity(FVC) were independent prognostic indicators of IPF. Conclusion IPF patients who have clubbing, PAH, a higher FEV1/FVC, and a short duration from initial onset to diagnosis have a poorer outcome.
引用
收藏
页码:1868 / 1873
相关论文
共 50 条
  • [21] Clinical features of idiopathic pulmonary fibrosis with lung cancer
    Uematsu, K
    Seike, M
    Yoshimura, A
    Shibuya, M
    Kudoh, S
    Kiyoshi, T
    Kamio, K
    Okano, T
    Watanabe, S
    Yamamoto, K
    Hasegawa, K
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A64 - A64
  • [22] Familial idiopathic pulmonary fibrosis - Clinical features and outcome
    Lee, HL
    Ryu, JH
    Wittmer, MH
    Hartman, TE
    Lymp, JF
    Tazelaar, HD
    Limper, AH
    CHEST, 2005, 127 (06) : 2034 - 2041
  • [23] Clinical features of patients with idiopathic pulmonary upper lobe-dominant fibrosis
    Shinomiya, Shun
    Usui, Yutaka
    Kaga, Akiko
    Nagta, Makoto
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [24] Lifestyle Behaviors and Clinical Outcomes in Idiopathic Pulmonary Fibrosis
    Vainshelboim, Baruch
    Oliveira, Jose
    Izhakian, Shimon
    Unterman, Avraham
    Kramer, Mordechai Reuven
    RESPIRATION, 2018, 95 (01) : 27 - 34
  • [25] Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis
    Kreuter, Michael
    Lederer, David J.
    Cottin, Vincent
    Kahn, Nicolas
    Ley, Brett
    Vancheri, Carlo
    Weycker, Derek
    Atwood, Mark
    Kirchgaessler, Klaus-Uwe
    Ryerson, Christopher J.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (06)
  • [26] DEFINING BENCHMARKS FOR CLINICAL OUTCOMES IN IDIOPATHIC PULMONARY FIBROSIS
    Cohen, A. H.
    Bradford, W. Z.
    Glassock, K. F.
    Weber, F.
    THORAX, 2012, 67 : A119 - A119
  • [27] Comparison of clinical outcomes in idiopathic pulmonary fibrosis patients with and without hiatal hernia
    Ayten, Omer
    Okutan, Oguzhan
    Kismet, Gozde Kalbaran
    Turkoglu, Ozlem
    Samanci, Cesur
    Caliskan, Tayfun
    Canoglu, Kadir
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2022, 70 (02): : 113 - 121
  • [28] The clinical course of patients with idiopathic pulmonary fibrosis
    Martinez, FJ
    Safrin, S
    Weycker, D
    Starko, KM
    Bradford, WZ
    King, TE
    Flaherty, KR
    Schwartz, DA
    Noble, PW
    Raghu, G
    Brown, KK
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (12) : 963 - 967
  • [29] Longitudinal Changes in Clinical Features, Management, and Outcomes of Idiopathic Pulmonary Fibrosis A Nationwide Cohort Study
    Moon, Sung Woo
    Kim, Song Yee
    Chung, Man Pyo
    Yoo, Hongseok
    Jeong, Sung Hwan
    Kim, Dong Soon
    Song, Jin Woo
    Lee, Hong Lyeol
    Choi, Sun Mi
    Kim, Young Whan
    Kim, Yong Hyun
    Park, Choon-Sik
    Park, Sung-Woo
    Park, Jong Sun
    Jegal, Yangjin
    Lee, Jongmin
    Uh, Soo-Taek
    Kim, Tae-Hyung
    Lee, Jae Ha
    Kim, Yee Hyung
    Shin, Bumsu
    Lee, Hyun-kyung
    Yang, Sei-Hoon
    Lee, Hyun
    Kim, Sang-Heon
    Lee, Eun-Joo
    Choi, Hye Sook
    Shin, Hyejung
    Park, Yong Bum
    Shin, Jong Wook
    Park, Moo Suk
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (05) : 780 - 787
  • [30] A Newfoundland cohort of familial and sporadic idiopathic pulmonary fibrosis patients: clinical and genetic features
    Bridget A Fernandez
    George Fox
    Rick Bhatia
    Eric Sala
    Barbara Noble
    Nash Denic
    Dzintra Fernandez
    Nigel Duguid
    Amanda Dohey
    Fady Kamel
    Laura Edwards
    Krista Mahoney
    Susan Stuckless
    Patrick S Parfrey
    Michael O Woods
    Respiratory Research, 13